2012
DOI: 10.1007/s00264-012-1668-5
|View full text |Cite
|
Sign up to set email alerts
|

Inhibiting wear particles-induced osteolysis with naringin

Abstract: Purpose The purpose of this study was to determine the effects of naringin on osteoclastogenesis and osteolysis both in vitro and in vivo. Methods In this research osteoclasts were generated from mouse bone marrow monocytes with the receptor activator of NF-КB ligand and the macrophage colony stimulating factor. Naringin, at a concentration of 1, 10, 50, and 100 μg/ mL, was respectively added to the medium. Seven days later, the osteoclasts were determined through tartrateresistant acid phosphatase (TRAP) stai… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 15 publications
(18 citation statements)
references
References 25 publications
0
18
0
Order By: Relevance
“…Aseptic-loosening-induced failure following arthroplasty surgery greatly influences the long-term survival of a total joint replacement [21]. Although the precise mechanism requires further investigation, the presence of metallic wear particles from total joint implants appears to be associated with significant increases in inflammation and osteoclastogenesis, which are vital and central events in periprosthetic osteolysis [22].…”
Section: Discussionmentioning
confidence: 99%
“…Aseptic-loosening-induced failure following arthroplasty surgery greatly influences the long-term survival of a total joint replacement [21]. Although the precise mechanism requires further investigation, the presence of metallic wear particles from total joint implants appears to be associated with significant increases in inflammation and osteoclastogenesis, which are vital and central events in periprosthetic osteolysis [22].…”
Section: Discussionmentioning
confidence: 99%
“…Naringin (C 27 H 32 O 14 , CAS 10236-47-2) is a double-hydrogen flavonoids compound, its chemical name is naringenine-7-rhamnosidoglucoside (structure is shown in Fig. 1).…”
Section: Introductionmentioning
confidence: 99%
“…These studies can be divided into two classes based on systemic treatment or locally applied treatment. Systemic agents applied to intercede in particle-dependent bone resorption include a spectrum of different agents targeting multiple cellular pathways that alter macrophage, osteoblast, and osteoclast metabolism [16,58]. These agents include estrogen receptor antagonist to block TNF production and luteolin to inhibit TNF, both agents reducing osteolysis [29,42].…”
Section: Search Strategy and Criteriamentioning
confidence: 99%